The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy
Abstract
Clinicians use a range of clinical and objective measures to quantify the positive and negative features (impairments) of the upper motor neurone syndrome. These measures play an important role in the assessment and selection of suitable candidates for intervention and monitoring of outcome. Intervention strategies often focus on the positive features; however, outcome may be more contingent upon the severity of the negative features. The clinical protocol for patient selection and treatment used by our multidisciplinary team is presented, together with details of the assessment procedure. Measurement tools in routine use are described, including: the Modified Ashworth Scale, the Modified Tardieu Scale (‘R1’), muscle length by joint range of motion ‘R2’, three‐dimensional gait analysis, assessments of strength by the Medical Research Council Scale, Selective Motor Control, the Gross Motor Function Measure and the Observational Gait Scale. Three case studies of children with cerebral palsy who underwent botulinum toxin type A treatment as part of their management of gait disorder are presented, a 2‐year‐old girl with mild hemiplegia (‘true equinus’), a 3‐year‐old boy with moderate hemiplegia (‘apparent equinus’) and a 6‐year‐old girl with diplegia, where a targeted approach was used to treat a distal problem and resulted in correction Of a proximal problem.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palisano, R., Rosenbaum, P., Walter, S., Russell, D., Wood, E., & Galuppi, B. (1997) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1997.tb07414.x · Cited by 6,721
Interrater Reliability of a Modified Ashworth Scale of Muscle Spasticity
Bohannon, R. W., & Smith, M. B. (1987) · Physical Therapy · doi:10.1093/ptj/67.2.206 · Cited by 5,424
A gait analysis data collection and reduction technique
Davis, R. B., Õunpuu, S., Tyburski, D., & Gage, J. R. (1991) · Human Movement Science · doi:10.1016/0167-9457(91)90046-z · Cited by 3,086
Gait patterns in spastic hemiplegia in children and young adults
(1987) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-198769030-00016 · Cited by 524
Lower‐Extremity strength profiles in spastic cerebral palsy
Wiley, M. E., & Damiano, D. L. (1998) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1998.tb15369.x · Cited by 491
Msall, M. E., DiGaudio, K., Rogers, B. T., LaForest, S., Catanzaro, N. L., Campbell, J., Wilczenski, F., & Duffy, L. C. (1994) · Clinical Pediatrics · doi:10.1177/000992289403300708 · Cited by 425
Recommendations for the use of botulinum toxin type A in the management of cerebral palsy
Graham, H. K., Aoki, K. R., Autti-Rämö, I., Boyd, R. N., Delgado, M. R., Gaebler-Spira, D. J., Gormley, M. E., Guyer, B. M., Heinen, F., Holton, A. F., et al. (2000) · Gait & Posture · doi:10.1016/s0966-6362(99)00054-5 · Cited by 399
Self-citationBOTULINUM TOXIN IN THE MANAGEMENT OF THE LOWER LIMB IN CEREBRAL PALSY
Cosgrove, A. P., Corry, I. S., & Graham, H. K. (1994) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1994.tb11864.x · Cited by 354
Self-citationExtrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection
Rosales, R. L., Arimura, K., Takenaga, S., & Osame, M. (1996) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199604)19:4<488::aid-mus9>3.0.co;2-8 · Cited by 339
Botulinum a Toxin Effects on Rat Jaw Muscle Spindles
Filippi, G. M., Errico, P., Santarelli, R., Bagolini, B., & Manni, E. (1993) · Acta Oto-Laryngologica · doi:10.3109/00016489309135834 · Cited by 339
Cited by
Koman, L. A., Smith, B. P., & Shilt, J. S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16207-7 · Cited by 459
Spasticity after stroke: Physiology, assessment and treatment
Thibaut, A., Chatelle, C., Ziegler, E., Bruno, M.-A., Laureys, S., & Gosseries, O. (2013) · Brain Injury · doi:10.3109/02699052.2013.804202 · Cited by 447
Rodda, J., & Graham, H. K. (2001) · European Journal of Neurology · doi:10.1046/j.1468-1331.2001.00042.x · Cited by 425
Self-citationRecommendations for the use of botulinum toxin type A in the management of cerebral palsy
Graham, H. K., Aoki, K. R., Autti-Rämö, I., Boyd, R. N., Delgado, M. R., Gaebler-Spira, D. J., Gormley, M. E., Guyer, B. M., Heinen, F., Holton, A. F., et al. (2000) · Gait & Posture · doi:10.1016/s0966-6362(99)00054-5 · Cited by 399
Self-citationA systematic review of the Tardieu Scale for the measurement of spasticity
Haugh, A. B., Pandyan, A. D., & Johnson, G. R. (2006) · Disability and Rehabilitation · doi:10.1080/09638280500404305 · Cited by 351
Metadata
- Authors
- Boyd, R. N., & Graham, H. K.
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 1999-11
- Volume
- 6
- Issue
- S4
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- OpenAlex
- W2069240566
- Cited by
- 553
- References
- 19
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. https://app.cochat.ai/papers/10.1111/j.1468-1331.1999.tb00031.x
- The paper
- Boyd, R. N., & Graham, H. K. (1999). Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. European Journal of Neurology. https://doi.org/10.1111/j.1468-1331.1999.tb00031.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.